4
Changes in Ownership
Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-21-089393
Options or other derivatives
- Chief Financial Officer acquired 270,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/tm2121425-2_4seq1.xml…